Alkermes' (ALKS) Neutral Rating Reiterated at HC Wainwright

HC Wainwright restated their neutral rating on shares of Alkermes (NASDAQ:ALKS – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $34.00 price target on the stock. Other analysts also recently issued reports about the company. JPMorgan Chase & Co. lifted their price target on Alkermes from $29.00 to […]

Related Keywords

Ireland ,United States ,Nancy Wysenski ,Piper Sandler ,Christian Todd Nichols ,Cantor Fitzgerald ,Securities Exchange Commission ,Jpmorgan Chase Co ,Virtu Financial ,Ea Series ,Alkermes ,Financial Group ,Simplicity Solutions ,Vanguard Personalized Indexing Management ,Free Report ,Moderate Buy ,Stock Down ,Get Free Report ,Director Nancy Wysenski ,Todd Nichols ,Exchange Commission ,Personalized Indexing Management ,Alkermes Daily ,Nasdaq Alks ,Talks ,Medical ,G0176710 ,Reiterated Rating ,Hc Wainwright ,